UNSPSC 51282203: Flomoxef

This classification denotes a cephalosporin antibiotic with the molecular formula C15H18F2N6O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9E5U5XF42, chemically known as (-)-(6r,7r)-7-(2-((difluoromethyl)thio)acetamido)-3-(((1-(2-hydroxyethyl)-1h-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as flomoxef, which bears US NIH Compound Identifier 65864.

UNSPSC 51282203 Flomoxef, a Commodity code, nominally addresses a specific antibiotic pharmaceutical product, but recent state and local procurement activity under this code shows minimal direct relevance to the code's narrow scope. The two most recent opportunities posted under this code do not involve flomoxef procurement; instead, they document pharmaceutical and medical supply acquisitions covering other antibiotics, naloxone, and drug deactivation systems. State and local health departments and county public health agencies use this code to solicit emergency pharmaceuticals, opioid-reversal medications, and related medical supplies through cooperative purchasing vehicles and competitive bidding processes. The issuing bodies include state departments of public health and county health departments pursuing community health and emergency preparedness initiatives.

Illinois Department of Public Health completed an award to Chartwell Rx LLC on August 28, 2026, for doxycycline and ciprofloxacin through the MMCAP Infuse cooperative purchasing consortium (solicitation 26482DPHPREPDB53392, $2,999,999.11 over 12 months with two one-year renewal options), and Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 drug deactivation systems with quarterly deliveries required. Illinois and Florida are the jurisdictions with recorded recent activity under this code. The code shows sparse recent opportunity volume and a disconnect between its nominal pharmaceutical scope and the actual work state and local buyers are pursuing through it.